Madrigal Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
/ 
Frequently asked questions
To buy Madrigal Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Madrigal Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Madrigal Pharmaceuticals Inc. is MDGL:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Madrigal Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Madrigal Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Madrigal Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Madrigal Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Madrigal Pharmaceuticals Inc..